Novo Nordisk Inhaled Insulin To Resume Phase III Studies
Trials for the AERx inhaled insulin system will involve both type 1 and type 2 diabetes, despite a previous safety signal in type 1 patients.
Trials for the AERx inhaled insulin system will involve both type 1 and type 2 diabetes, despite a previous safety signal in type 1 patients.